Blog
RSS FeedPosted by Michael Wonder on 21 Mar 2024
New leaders for medicines and medical services committees
20 March 2024 - Two esteemed medical experts have been appointed to oversee the committees that advise Government on funding medicines, ...
Posted by Michael Wonder on 01 Mar 2024
More rare conditions considered for newborn bloodspot screening and new treatment option for spinal muscular atrophy
29 February 2024 - On Rare Disease Day, the Albanese Government has announced two more rare genetic conditions have been ...
Posted by Michael Wonder on 31 May 2023
Streamlining SMC processes for medicines that clearly offer good value to NHSScotland
30 May 2023 - Following a positive stakeholder evaluation, a change to SMC process for medicines introduced on an interim ...
Posted by Michael Wonder on 16 Feb 2023
Living health technology assessments: how close to living reality?
16 February 2023 - HTA processes have remained largely unchanged, but innovative study designs (eg, pragmatic and adaptive clinical trials, single-arm ...
Posted by Michael Wonder on 08 Feb 2023
Speeding up access to new medicines in Scotland: abbreviated process
8 February 2023 - A process brought in to streamline decision-making around access to new medicines in NHSScotland during the ...
Posted by Michael Wonder on 12 Sep 2022
Nomination for an early re-entry resubmission - what exactly does it mean?
12 September 2022 - We compare and contrast the submissions nominated by the PBAC in March for an early re-entry ...
Posted by Michael Wonder on 02 Jun 2022
Hope for change after PHARMAC independent review
2 June 2022 - A woman who had her bowel removed while she waited for drugs that would probably have ...
Posted by Michael Wonder on 01 Jun 2022
Government response to independent PHARMAC review
1 June 2022 - The Government has released its response to the recommendations of the final report of the independent ...
Posted by Michael Wonder on 29 May 2022
Application accompanying data collection in the case of market access for several active substances in a class: IQWiG presents a concept
27 May 2022 - The institute recommends platform studies under a master's protocol. ...
Posted by Michael Wonder on 10 May 2022
Calls for Health Minister to release final report from PHARMAC review
11 May 2022 - Health Minister Andrew Little is facing calls to release the final report from a review of ...
Posted by Michael Wonder on 19 Jan 2022
UK’s NICE to launch sweeping changes to drug assessments to be faster, more agile
19 January 2022 - The health technology assessment body has been under pressure from drugmakers and patient groups for years to ...
Posted by Michael Wonder on 19 Apr 2021
NICE launches ambitious strategy to provide quicker access to new treatments and innovations
19 April 2021 - NICE will transform key elements of its approach to ensure efficiency and speed while maintaining robust, trusted ...
Posted by Michael Wonder on 30 Mar 2021
NICE methods and process review aims to create fertile ground for innovation
29 March 2021 - The way NICE reviews new medicines is about to go through its biggest change in years – ...
Posted by Michael Wonder on 01 Oct 2020
New procedures for CADTH drug reimbursement reviews
30 September 2020 - CADTH initiated stakeholder consultations in June 2020 on proposals to align the procedure for its drug ...
Posted by Michael Wonder on 16 Jul 2020
Mallinckrodt and Terumo BCT announce positive recommendations for public funding of Uvadex (methoxsalen) for ECP administration with the Therakos CE
13 July 2020 - In a rare dual-review process, two independent advisory committees to the Australian Minister for Health recommend reimbursement ...